Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2025-12-24 @ 9:23 PM
NCT ID:
NCT00190632
Eligibility Criteria:
Inclusion Criteria:
Have had symptoms of SUI for at least 3 months prior to study entry.
Have urine leakage most often associated with activity (such as coughing, sneezing, exercise).
Ambulatory and able to use a toilet independently and without difficulty.
\-
Exclusion Criteria:
Subjects who participated or were discontinued from any previous studies investigating duloxetine.
Use of excluded medications within 14 days prior to study entry or at any time during the study.
Subjects who currently have or have had a history of urogenital cancer.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00190632
Study Brief:
Protocol Section:
NCT00190632